MMP | VJOncology - Behind the Camera at ESMO GI 2026

The teams at VJOncology were set for an exciting week of scientific development and collaboration as they headed to Munich for the 2026 European Society for Medical Oncology (ESMO) Gastrointestinal (GI) Cancers Congress. Taking place between 1–4 July, the congress brought together oncologists, researchers and industry partners from around the world.

The editorial team were highly engaged throughout ESMO GI, conducting back-to-back interviews with world-renowned KOLs, capturing the meeting’s most impactful scientific insights. The notable volume of interviews reflects the scale of new advances in prevention, diagnosis and treatment highlighted at this year’s congress.

The content from the congress is currently hosted on our dedicated ESMO GI page on VJOncology. If you are interested in supporting Independent Medical Education through our channels, please get in touch here.

Our Editors’ Top Picks from ESMO GI 2026

At every major congress, our editors handpick the abstracts they feel offer the most practice-changing insights or the most exciting developments.

Here are the picks from ESMO GI:

HERIZON-GEA-01: HRQoL with first-line zanidatamab-based regimens in HER2+ mGEA - Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan

ESMO GI 2026 | EMERALD-3 & EMERALD-1 reshape TACE strategies in HCC at ESMO GI 2026 - Silvio Ken Garattini, MD, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy

GALAXY: upfront surgery with adjuvant chemotherapy improved outcomes in MRD+ patients with CRC - Kozo Kataoka, MD, Hyogo Medical University, Nishinomiya, Japan

CAPRI-2 GOIM: ctDNA-guided cetuximab sequencing in colorectal cancer - Giulia Martini, MD, PhD, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

Four-year real-world outcomes of atezolizumab and bevacizumab in HCC - Julien Edeline, MD, PhD, Centre Eugene Marquis, Rennes, France

ESMO GI 2026 pancreatic cancer highlights: KRAS inhibitors, TRIPP-FFX, and PROCEADE-PanTumor - Teresa Macarulla, MD, Vall d’Hebron University Hospital, Barcelona, Spain

About VJOncology
The Video Journal of Oncology (VJOncology) is a leader in oncology news and education, providing healthcare professionals from around the globe with easy access to the latest updates in solid tumor research and expert opinion. Our Editorial Board and Team work closely to capture the most important and relevant information from major congresses and meetings, presenting this in engaging and easily-digestible digital formats for community oncologists to explore.

The continued success of VJOncology is in no small part down to independent support from industry. If you’re interested in supporting one of our Disease Channels or one of our other medical education programs, please get in contact with us here.